Aidence

About:

Aidence provides AI solutions for the lung cancer pathway.

Top Investors: henQ, Inkef, Northzone, SBRI Healthcare, Rabo Ventures

Description:

Aidence rallies 80+ data scientists, software engineers, medical, regulatory, and business professionals to provide intelligent software for the lung cancer pathway. Their first clinical application is Veye Lung Nodules, an AI solution for pulmonary nodule management on CTs. Veye is running in routine practice and lung cancer screening programmes across Europe.

Total Funding Amount:

$14.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Amsterdam, Noord-Holland, The Netherlands

Founded Date:

2015-01-01

Contact Email:

info(AT)aidence.com

Founders:

Jeroen Van Duffelen, Mark-Jan Harte